Showing results (171-180 of 3,655) with videos related to

Sort By:
Pageof 366
Breast Cancer Research : BCR|June 16, 2025
Discovery and validation of cell-free DNA methylation markers for specific diagnosis, differentiation from benign tumors, and prognosis of breast cancerLijing Gao, Lei Zhang, Jinyin Liu, et al.
Breast Cancer Research : BCR|June 17, 2025
Exploratory multi-cohort, multi-reader study on the clinical utility of a deep learning model for transforming cryosectioned to formalin-fixed, paraffin-embedded (FFPE) images in breast lesion diagnosisXue Chao, Yu Wu, Xi Cai, et al.
Breast Cancer Research : BCR|June 16, 2025
Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patientsAlexis Wilhelm, Charlotte Flynn, Evelyn Hammer, et al.
Breast Cancer Research : BCR|June 13, 2025
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric studyKaren Van Baelen, Ha-Linh Nguyen, François Richard, et al.
Breast Cancer Research : BCR|May 13, 2025
Association between transcriptomic metrics of exogenous antigen presentation and adaptive immunity with locoregional recurrence in localized estrogen receptor negative breast cancer: retrospective review of multi-institutional datasetsTimothy J Robinson, Casey L Liveringhouse, Christopher Wilson, et al.
Breast Cancer Research : BCR|May 12, 2025
Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancerPhilipp Heumann, Axel Benner, Sabine Behrens, et al.
Breast Cancer Research : BCR|March 22, 2025
Evolutionary measures show that recurrence of DCIS is distinct from progression to breast cancerAngelo Fortunato, Diego Mallo, Luis Cisneros, et al.
Breast Cancer Research : BCR|December 19, 2003
Prevention of mammary carcinogenesis by short-term estrogen and progestin treatmentsLakshmanaswamy Rajkumar, Raphael C Guzman, Jason Yang, et al.
Breast Cancer Research : BCR|March 19, 2013
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancerJohn F R Robertson, J Michael Dixon, D Mark Sibbering, et al.
Breast Cancer Research : BCR|March 20, 2013
Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancersMarketa Zvelebil, Erik Oliemuller, Qiong Gao, et al.
Pageof 366